Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Оценка числа предотвращенных смертей от рака благодаря профилактике, скринингу и лечению, 1975–2020 гг.
Katrina A.B. Goddard, Eric J. Feuer, Jeanne S. Mandelblatt, Rafael Meza, Theodore R. Holford, Jihyoun Jeon, Iris Lansdorp‐Vogelaar, Roman Gulati, Natasha K. Stout, Nadia Howlader, Amy B. Knudsen, Daniel G. Miller, Jennifer Lee Caswell-Jin, Clyde B. Schechter, Ruth Etzioni, Amy Trentham‐Dietz, Allison W. Kurian, Sylvia K. Plevritis, John M. Hampton, Sarah J. Stein, Liyang P. Sun, Asad Umar, Philip E. Castle
2024-12-05

Cancer Intervention and Surveillance Modeling Networkcancer deaths avertedcancer mortalitycancer preventioncancer screening
Importance: Cancer mortality has decreased over time, but the contributions of different interventions across the cancer control continuum to averting cancer deaths have not been systematically evaluated across major cancer sites. Objective: To quantify the contributions of prevention, screening (to remove precursors [interception] or early detection), and treatment to cumulative number of cancer deaths averted from 1975 to 2020 for breast, cervical, colorectal, lung, and prostate cancers. Design, Setting, and Participants: In this model-based study using population-level cancer mortality data, outputs from published models developed by the Cancer Intervention and Surveillance Modeling Network were extended to quantify cancer deaths averted through 2020. Model inputs were based on national data on risk factors, cancer incidence, cancer survival, and mortality due to other causes, and dissemination and effects of prevention, screening (for interception and early detection), and treatment. Simulated or modeled data using parameters derived from multiple birth cohorts of the US population were used. Interventions: Primary prevention via smoking reduction (lung), screening for interception (cervix and colorectal) or early detection (breast, cervix, colorectal, and prostate), and therapy (breast, colorectal, lung, and prostate). Main Outcomes and Measures: The estimated cumulative number of cancer deaths averted with interventions vs no advances. Results: An estimated 5.94 million cancer deaths were averted for breast, cervical, colorectal, lung, and prostate cancers combined. Cancer prevention and screening efforts averted 8 of 10 of these deaths (4.75 million averted deaths). The contribution of each intervention varied by cancer site. Screening accounted for 25% of breast cancer deaths averted. Averted cervical cancer deaths were nearly completely averted through screening and removal of cancer precursors as treatment advances were modest during the study period. Averted colorectal cancer deaths were averted because of screening and removal of precancerous polyps or early detection in 79% and treatment advances in 21%. Most lung cancer deaths were avoided by smoking reduction (98%) because screening uptake was low and treatment largely palliative before 2014. Screening contributed to 56% of averted prostate cancer deaths. Conclusions and Relevance: Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for these causes; however, their contribution varied by cancer site according to these models using population-level cancer mortality data. Despite progress, efforts to reduce the US cancer burden will require increased dissemination of effective interventions and new technologies and discoveries.
1
From 1975 to 2020, an estimated 5.94 million deaths from breast, cervical, colorectal, lung, and prostate cancers were averted.
2
Nearly all cervical cancer deaths averted were attributed to screening and removal of precancerous lesions, while treatment advances contributed modestly.
3
Prevention and screening accounted for 4.75 million averted deaths, representing approximately 8 of every 10 deaths prevented.
4
Screening accounted for 25% of breast cancer deaths averted.
5
The relative contribution of prevention, screening, and treatment varied substantially across cancer sites.

Breast, cervical, colorectal, lung, and prostate cancers in the US population from 1975 to 2020

The contributions of prevention, screening, and treatment interventions to the cumulative number of cancer deaths averted

Publication Details
Publication Date
2024-12-05
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Katrina A.B. Goddard
Eric J. Feuer
Jeanne S. Mandelblatt
Rafael Meza
Theodore R. Holford
Jihyoun Jeon
Iris Lansdorp‐Vogelaar
Roman Gulati
Natasha K. Stout
Nadia Howlader
Amy B. Knudsen
Daniel G. Miller
Jennifer Lee Caswell-Jin
Clyde B. Schechter
Ruth Etzioni
Amy Trentham‐Dietz
Allison W. Kurian
Sylvia K. Plevritis
John M. Hampton
Sarah J. Stein
Liyang P. Sun
Asad Umar
Philip E. Castle
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%